Yohei Doi   Takuma Ishihara   Sumi Banno   Masahiko Ando   Masashi Kondo   
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 29(2) 150-156 2022年10月
INTRODUCTION: Favipiravir, an antiviral agent with activity against SARS-CoV-2, was made available to hospitals in Japan for off-label use among COVID-19 patients between 2020 and 2021. METHODS: A nationwide observational cohort study was conducte...